ResourceDrug Discovery & Development
Fragment screening of massively parallel ligand arrays using the Carterra Ultra SPR platform
3 Nov 2025Fragment-based lead discovery (FBLD) demands technologies that can detect low-affinity interactions across vast chemical space, posing throughput and sensitivity challenges. Discover how high-throughput surface plasmon resonance (SPR) innovations dramatically expand ligand capacity, streamline hit-to-lead workflows, and enable simultaneous analysis of over 100 targets, accelerating decision-making in early-stage drug discovery.
Related products
Request Quote for All Products
Carterra Ultra™
CarterraDisruptive technology for the characterization of small molecules and fragments. With enhanced sensitivity, expanded thermal options, and advanced microfluidics, the Carterra Ultra™ platform is our most sensitive instrument for interrogating multiple proteins and off-target binding in parallel.
Links
Tags
High-Throughput ScreeningHigh-throughput screening (HTS) is an automated drug discovery technique for identification of active compounds against a compound library. Use HTS readers and integrated assay preparation / analysis workstations to screen your compounds. Identify active compounds against various HTS libraries, including membranes, proteins and peptides and HTS cell lines. Find the best high-throughput screening products in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.Ligands